Meet the Team: Jin Gong, Imaging Scientist

In our second post of the “Meet the Team” series, we sat down with Combinostics Imaging Scientist Jin Gong, to chat about her degrees, her personal connection with Alzheimer’s disease (AD), and her love of travel, gaming, and great bargains.

Continue Reading Meet the Team: Jin Gong, Imaging Scientist

Can AI help with patient selection for Aduhelm and other new disease-modifying drugs for Alzheimer’s disease?

Drug development and selection of drugs for patients in clinical practice for Alzheimer's disease are challenged by many factors, including patient heterogeneity. AI had the potential to help select patients for whom a drug is most suitable — in trials and in practice.

Continue Reading Can AI help with patient selection for Aduhelm and other new disease-modifying drugs for Alzheimer’s disease?

RSNA 2021

Attending RSNA 2021? Stop by Booth #4937 in the AI Showcase and chat about cMRI, cDSI and more for automated MRI biomarker detection and quantification.

Continue Reading RSNA 2021

A novel CT-based automated analysis method provides comparable results with MRI in measuring brain atrophy and white matter lesions

Neuroradiology A.L. Kaipainen, J. Pitkänen, F. Haapalinna, O. Jääskeläinen, H. Jokinen, S. Melkas, T. Erkinjuntti,…

Continue Reading A novel CT-based automated analysis method provides comparable results with MRI in measuring brain atrophy and white matter lesions

Change in CAIDE dementia risk score and neuroimaging biomarkers during a 2-year multidomain lifestyle randomized controlled trial: results of a post-hoc subgroup analysis

The Journals of Gerontology Series A: Biological Sciences and Medical Sciences M. Peltonen, R. Antikainen,…

Continue Reading Change in CAIDE dementia risk score and neuroimaging biomarkers during a 2-year multidomain lifestyle randomized controlled trial: results of a post-hoc subgroup analysis